ââ?¬Å?EFFECT OF VITAMIN E & C SUPPLEMENTATION ON THROMBOCYTOPENIA IN DENGUE FEVERââ?¬? ââ?¬â?? A RANDOMISED CONTROLLED TRIA

Not Applicable

• Conditions: Health Condition 1: A00-B99- Certain infectious and parasitic diseasesHealth Condition 2: A90- Dengue fever [classical dengue]

• Registration Number: CTRI/2022/09/045521
• Lead Sponsor: Srikanth

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Children between the ages of 5-18 years and who fulfilled the clinical criteria of dengue fever (fever and 2 of the symptoms: headache, retro-orbital pain, myalgia, arthralgia, bone pain and hemorrhagic manifestations) with diagnosed NS1AG positive or dengue IgG anspd IgM positive

2. Patients of dengue fever (as per WHO criteria) with thrombocytopenia ( platelet count < 1.5lakhs)

Exclusion Criteria

1. Patients of dengue fever with platelet counts > 1.5lakhs

2. Patients who already started on vitamin E and vitamin C supplementation prior to admission

3. Patients of dengue fever with severe thrombocytopenia requiring platelet transfusion.

4. Patients of dengue fever with severe GI bleeding manifestations

Study & Design

• Study Type: Interventional
• Study Design: Not specified